Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Developments and Operations
MCK logo

McKesson Pivots to Oncology with $3.3 Billion in Acquisitions and New Segment Structure

MCK10-QFiling Date: 2/4/2026
McKesson Corporation
Description

What this story covers

McKesson is transforming, with 3.3 billion dollars in oncology acquisitions and a new structure. Despite 497 million dollars in opioid payments, 13 percent pharmaceutical revenue growth shows operational strength. A Medical-Surgical spin-off is planned.

Story snapshot

CompanyMcKesson Corporation
TickerMCK
VariantStandard detailed
Duration12:29
Filing type10-Q
PeriodQ4 2025
IndustryHealthcare & Pharmaceuticals
Accession0000927653-26-000017
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in